Keyphrases
Comparative Effectiveness
100%
Medicare Part D
100%
Sevelamer
100%
Calcium Acetate
100%
Elderly Hemodialysis Patients
100%
Clinical Outcomes
100%
System Data
22%
Low Risk
22%
United States Renal Data System (USRDS)
22%
Hospital Days
22%
Risk of Death
22%
Low-income Subsidy
22%
Incident Hemodialysis Patients
22%
Medicare
11%
Cardiovascular Mortality
11%
Therapeutic Potential
11%
Multivariable
11%
Prescription Drugs
11%
Young Patients
11%
Hospital Admission
11%
Hyperphosphatemia
11%
Hemodialysis Patients
11%
Propensity Score Matching
11%
No Significant Difference
11%
Laboratory Data
11%
Multiple Hospitalization
11%
Hospitalization Risk
11%
First Hospitalization
11%
Binder
11%
Survival Benefit
11%
Observational Cohort Study
11%
Referent Group
11%
Phosphate Binder
11%
Hospitalization Days
11%
Matched Cohort
11%
Over-the-counter
11%
Sevelamer Carbonate
11%
Sevelamer Hydrochloride
11%
Admission Day
11%
Medicare Part A
11%
Drug Data
11%
Medicine and Dentistry
Medicare
100%
Hemodialysis
100%
Sevelamer
100%
Calcium Acetate
100%
Cardiovascular System
33%
Isotopes of Calcium
11%
Outcome Assessment
11%
Hospital Mortality
11%
Phosphate Binder
11%
Hyperphosphatemia
11%
Prescription Drug
11%
Cohort Study
11%
Sevelamer Carbonate
11%
Pharmacology, Toxicology and Pharmaceutical Science
Hemodialysis
100%
Sevelamer
100%
Calcium Acetate
100%
Cohort Study
11%
Prescription Drug
11%
Hospital Mortality
11%
Phosphate Binding Agent
11%
Sevelamer Carbonate
11%
Hyperphosphatemia
11%